More of New Meningitis Vaccine for Africa

摘要

An affordable, effective vaccine against deadly bacterial meningitis A will be rolled out in three more African countries this year, thanks to $100 million in new funds from the GAVI Alliance, a public-private global health partnership. Massive immunization campaigns will start in Cameroon, Chad, and Nigeria by December, ahead of the dry season when epidemics sweep across the so-called meningitis belt of Africa. MenAfriVac is the first vaccine developed specifically for Africa, at a price poor governments can afford—roughly 50 cents per dose.